Stockholm, Sweden

Fredrik Frejd

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I will be happy to assist you in creating the article about inventor Fredrik Frejd based on the data provided.

Title: Innovator Spotlight: Fredrik Frejd - Pioneering Advancements in Biomedical Imaging and Therapeutics

Introduction: Fredrik Frejd, a distinguished inventor based in Stockholm, SE, has made significant contributions to the field of biotechnology with a groundbreaking portfolio of 10 patents.

Latest Patents:

1. HER2 binders - Fredrik Frejd's innovative patent involves imaging agents comprising an isolated polypeptide conjugated with a radionucleide and a chelator, specifically binding to HER2, or variants thereof.

2. IL-17A-binding polypeptides - His patent showcases engineered polypeptides with a binding affinity for interleukin-17A (IL-17A), offering diagnostic, prognostic, and therapeutic applications.

Career Highlights: Fredrik Frejd has excelled in his roles at prominent companies like Affibody AB and General Electric Company, where he has spearheaded cutting-edge research in biopharmaceuticals and medical imaging technologies.

Collaborations: Throughout his career, Fredrik has collaborated closely with esteemed peers such as Elin Gunneriusson and Joachim Feldwisch, fostering a collaborative environment and facilitating the exchange of innovative ideas.

Conclusion: Fredrik Frejd's outstanding work in developing novel imaging agents and therapeutic polypeptides underscores his commitment to advancing biomedicine. His collaborative spirit and inventive prowess continue to shape the landscape of biomedical innovation, leaving a lasting impact on the field.

If you need further assistance or more details, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…